ALKS vs DOCU · P/E 14, rev $1.56B vs P/E 15, rev $2.98B
Alkermes Plc (ALKS) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
DocuSign Inc (DOCU) is a software - application company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the ALKS and DOCU stock pages for the full models.
Not investment advice.